Ex vivo expansion of CD4(+)CD25(+) T regulatory cells for immunosuppressive therapy.

  title={Ex vivo expansion of CD4(+)CD25(+) T regulatory cells for immunosuppressive therapy.},
  author={Piotr Trzonkowski and Magdalena Szaryńska and Jolanta M. Myśliwska and Andrzej Myśliwski},
  journal={Cytometry. Part A : the journal of the International Society for Analytical Cytology},
  volume={75 3},
Immunosuppressants are powerful drugs, capable of triggering severe adverse effects. Hence, there is tremendous interest in replacing them with less-toxic agents. Adoptive therapy with CD25(+)CD4(+) T regulatory cells (Tregs) holds promise as an alternative to immunosuppressants. Tregs have been described as the most potent immunosuppressive cells in the human body. In a number of experimental models, they have been found to quench autoimmune diseases, maintain allogeneic transplants, and… CONTINUE READING
31 Citations
192 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 31 extracted citations


Publications referenced by this paper.
Showing 1-10 of 192 references

Calcineurin inhibitors, but not rapamycin, reduce percentages of CD41CD251FOXP31 regulatory T cells in renal transplant recipients

  • DS Segundo, JC Ruiz, +9 authors M. Arias
  • Transplantation
  • 2006
Highly Influential
14 Excerpts

Similar Papers

Loading similar papers…